Your trusted source for investing success

Tag: pricing

Tech Forecast and Promising Tech Stocks To Buy in 2017

Learn about breakthrough technology about to impact lives around the globe. We cover the entire industry in our FREE investor’s report.   Gain Access

Amicus Therapeutics Prices Underwritten Offering of Common Stock

Amicus Therapeutics (Nasdaq:FOLD) announced the pricing of an underwritten offering of 19,354,839 shares of its common stock at $15.50 per share. The gross proceeds from the offering to Amicus are expected to be $300 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Amicus.

As quoted in the press

Motus Goes Public on the NASDAQ

Motus Goes Public on the NASDAQ

Medical device company, Motus (NASDAQ:MOTS), made the switch from private to public today on the NASDAQ Capital market, but Renaissance Capital stated the company’s initial public offering (IPO) on the low side of $5 instead of a high of $7.

Avinger Announces Pricing of $18 Million Underwritten Public Offering

Avinger (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the pricing of an underwritten public offering of Series B convertible preferred stock, together with warrants, for gross proceeds of $18.0 million, prior to deducting underwriting discounts and commissions and offering expenses payable by Avinger.

As

Motus GI Announces Pricing of Initial Public Offering

Motus GI a medical technology company dedicated to improving endoscopy outcomes and experiences, announced today the pricing of its initial public offering of 3,500,000 shares of its common stock at a public offering price of $5.00 per share. All of the shares of common stock are being offered by Motus.

miRagen Therapeutics Prices Public Offering of Common Stock

miRagen Therapeutics (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced the pricing of its previously announced underwritten public offering of 7,000,000 shares of its common stock at a public offering price of $5.50 per share.

As quoted in the press release:
miRagen intends to

Gemphire Announces Pricing of $22 Million Public Offering of Common Stock

Gemphire Therapeutics (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia, Non Alcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis, announced the pricing of its previously announced underwritten public offering of 3,142,858 shares of its common stock at a public offering price of $7.00

Theratechnologies Announces Financial Results for Fiscal Year 2017

Theratechnologies (TSX:TH) announced its financial results for the year ended November 30, 2017.

As quoted in the press release:
Selling and market development expenses amounted to $7,985,000 for the three months ended November 30, 2017, compared to $3,762,000 for the comparable period of Fiscal 2016. The higher expenses in 2017 were largely due to

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
5 Top Weekly NASDAQ Tech Stocks: Index on Pace for Best Week in 6 Years

URL: https://investingnews.com/daily/tech-investing/data-investing/weekly-nasdaq-tech-stocks/